Overview
Status
Active
Registry date
2016-11-18
Registered address
ul. Armii Krajowej 3/160, 10-072 Olsztyn, Poland
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 11.80mMedianUSD 420.11kAverageUSD 1.50m
Net profit
This companyUSD 1.11mMedianUSD 16.90kAverageUSD 158.97k
Operating costs
This companyUSD 10.25mMedianUSD 386.14kAverageUSD 1.28m
Assets
This companyUSD 7.45mMedianUSD 159.38kAverageUSD 917.51k
Industry
Bank accounts
Registered as a VAT taxpayer on 2016-12-01. Active
09 1090 2718 0000 0001 5081 0700
12 1090 2718 0000 0001 6294 1951
62 1090 2718 0000 0001 4708 1163
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 24, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $162,757 | Warmińsko-Mazurska Agencja Rozwoju Regionalnego S.A. | |
| May 20, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $13,676 | Prezes Banku Gospodarstwa Krajowego | |
| Jan 2, 2020 | Regional investment aid | $144,792 | Warmińsko-Mazurska Agencja Rozwoju Regionalnego S.A. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-11-30 | Stworzenie centrum B+R w przedsiębiorstwie KANVET SP Z. O. O. SPÓŁKA KOMANDYTOWA | $144,792 | Regionalny Program Operacyjny Województwa Warmińsko-Mazurskiego na lata 2014-2020 | |
| 2020-07-06 | Opracowanie innowacyjnego dodatku paszowego (detoksykant deoxynivalenolu) z wykorzystaniem enzymów drożdżowych | $162,757 | Regionalny Program Operacyjny Województwa Warmińsko-Mazurskiego na lata 2014-2020 |
Tenders
No recorded participation in tenders.
Partners
| Partners |
|---|
Ryszard Kaniewski (49)Marital property community |
Kanvet Sp. z o.o. |
Manner of representation
The company is represented independently by the general partner – KANVET limited liability company with its registered office in Olsztyn, which is represented by each member of the management board independently.
Beneficial owners
| Person | Rights |
|---|---|
Ryszard Kaniewski (49) | Udziałowiec komplementariusza; Limited partner in a limited partnership, 100000.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Gabinet Weterynaryjny Vet-Comsp. z o.o. | $9,662,128.75 | vet-com.pl | |
| Trójmiejska Klinika Weterynaryjnasp. z o.o. | $6,341,733.42 | tkw24.pl | |
| Sensivetsp. z o.o. | $4,281,162.94 | zielonaaleja.pl | |
| Sweetvetsp. z o.o. | $4,014,513.43 | sweetvet.pl | |
| Instytut Ochrony Zwierzątsp. z o.o. | $2,023,541.10 | instytutochronyzwierzat.com | |
| Zviropolissp. z o.o. | $1,164,257.02 | zviropolis.pl | |
| Canfelissp. z o.o. | $1,142,623.99 | canfelis.pl | |
| Benkowski & Hajdo - Przychodnia Weterynaryjnasp. z o.o. | $796,769.39 | przychodniawet.pl | |
| Ol-Med Lecznice Weterynaryjnesp. z o.o. | $757,893.10 | ol-med.com | |
| Animal Pharma Zduny - P. Gasik i Wspólnicysp. j. | — | animal-pharma.com |
FAQ
The main business activity of Kanvet sp. z o.o. sp.k. focuses on veterinary activities.
The company was registered in the Polish National Court Register (KRS) on November 18, 2016.
The headquarters is located at: ul. Armii Krajowej 3, 10-072 Olsztyn.
The share capital of the company is PLN 100,000 (approx. $27,012).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $11,802,556 in 2025, which is a decrease of 1.6% compared to 2024.
Yes, the company recorded a net profit of $1,105,528 in 2025, meaning the company decreased its profit by 47.5%.
The largest operating cost category falls under other operating costs. This category amounted to $5,727,497 in 2025, representing 56% of all operating expenses.
Last updated: 2026-07-15